Cepheid Study Shows Molecular Point-of-Care Test Nearly Doubles Appropriate Treatment Rates for Vaginal Infections
Image: Cepheid Cepheid, the Danaher-owned molecular diagnostics company, has published results from the first randomized clinical trial evaluating a multiplex molecular test for vaginitis at…